>The accumulated losses are immaterial when considered next to >the growth potential for this stock.
Funny, I think that quote was taken directly from the research report by Morgan Stanley regarding Boston Chicken.
No, but I know a little bit about materiality. Chances are excellent the company will become profitable by the time its deficit in retained earnings gets to a billion. This isn't much for a new startup with a market capitalization like AMZN's.
If you think the governments of the world would allow ANY biotech company to profit massively from a cure for cancer, you're just insane, or stupid. The company, process, and methods would be instantly nationalized.
This absurd remark doesn't even warrant a response, but I'll give you one anyway. Don't know where you are, but in the US it doesn't work this way. In case you haven't noticed, the US Healthcare Industry has done quite well in maintaining control over its intellectual property (of course, it hardly matters, since we in the US are subsidizing the rest of the world by paying the US drug companies for the drugs consumed elsewhere ... however, I haven't noticed a lot of bootleg Viagra or Prozac out there...)
My sense is that I'm arguing with a fencepost here (and one who is ill-informed, at that), and I'm a busy person. So how about we agree to disagree and move on?
Nice talking with you... |
